Company / Working Capital
BIOMERICA INC Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$3.1M
FY2025
5-year range
$3.1M / $10.9M
FY2021-FY2025
Trend
-43.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 10 years, ranging from $3M in FY2025 to $13M in FY2020.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of -25.1%.
Declined from $11M to $3M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -24.9%
- 5-Year CAGR
- -25.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -25.1%, indicating a declining trend.
- In FY2025, working capital decreased 43.3% year-over-year.
- Peak working capital was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.1M | -43.3% |
| FY2024 | $5.5M | -49.1% |
| FY2023 | $10.9M | +46.3% |
| FY2022 | $7.4M | -6.5% |
| FY2021 | $7.9M | -40.3% |
| FY2020 | $13.3M | +311.4% |
| FY2019 | $3.2M | -9.9% |
| FY2018 | $3.6M | -2.6% |
| FY2017 | $3.7M | -15.0% |
| FY2016 | $4.3M | +11.9% |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026